Sunday, October 3rd 2010

10.00

Registration at Poster Session Venue

12.00

Panini & Pizza

Afternoon

14.30 - 16:30

Meet the experts

14:30 –16:30

IPLASS Board Meeting (closed to the IPLASS Board of Directors).

16.30

Shift to Main Meeting Venue

17.00

OPENING AND WELCOME REMARKS OF THE MEETING CHAIR:

IPLASS President, Ornella Parolini

17.30-18.30

Diana W. Bianchi (USA)
Opening Keynote Lecture:

Fetal cells in the adult female following pregnancy: an under-appreciated source of progenitor cells

19.30

Welcome cocktail with cheese and wine.

Monday, October 4th

SESSION I:

Immunology of transplantation

Chairs: Alexander Betz and Andrew Mellor

9.00 - 9:45

Kathryn J. Wood (UK)

Translating transplantation tolerance in the clinic: where are we, where do we go?

9:45 - 10:30

Cecilia Götherström (Sweden)
Immunomodulation by mesenchymal stem cells and clinical experience

10.30 - 11:00

Coffee Break

11:00 - 11:30

Sicco Scherjon (Netherlands)
Lessons from fetomaternal tolerance as a paradigm for transplantation tolerance.

12:30 - 13:30

Lunch at Poster Session Venue

13:30 - 15:00

Coffee with Poster Session and Stand Displays by Sponsor Companies involved in banking and cell therapy.

SESSION II:

Natural/physiological mechanisms to escape graft rejection: fetomaternal tolerance

Chairs: Kathryn Wood and Cecilia Götherström

15:30 - 16:15

Alexander G. Betz (UK)
Molecular mechanisms of immune tolerance

16:15 - 17:00

Andrew L. Mellor (USA)
Indoleamine 2,3 dioxygenase: a pivotal counter-regulatory switch at sites of inflammation

17.00

Coffee Break

17:20 - 18:00

Selected Oral Presentations

Tuesday, October 5th

SESSION III:

Stem cell potential and immunoloical characteristics of cells from different placental regions

Chairs: Heinz Redl and Stephen Strom

9:00-9:45

Ornella Parolini (Italy)

i) Structure of Placenta – Generalities

ii) Immunomodulatory properties of amniotic membrane-derived cells: in vitro and in vivo studies

9:45-10:30

Mark Weiss (America)

Properties of Wharton's jelly-derived mesenchymal stromal cells:  immune modulation.

11:00-11:30

Coffee Break

Chairs:Cesar Borlongan and Ursula Manuelpillai

 11.30-12.00

Susanne Wolbank (Austria)

Suitability of amniotic membrane and cells thereof for tissue regeneration approaches

12.00-12.30

Racheli Ofir (Israel)

Placenta derived mesenchymal like stromal cells- not all cells were created equal

12.30-14:30

Lunch with Poster session and Stand Displays by Sponsor Companies involved in banking and cell therapy.

15:00

Afternoon social programme followed by networking dinner at 20:00

SESSION IV:

Cell therapy approaches: differentiation versus paracrine effects

Chairs: Mark Weiss and Daniel Surbek

9:00 - 9:30

Stephen Strom (USA)

Amnion-derived cells to treat liver disease

9:30 - 10:00

Ursula Manuelpillai (Australia)

Human amnion epithelial cells:a cellular therapy for inflammatorydiseases?

10:00-10.30

Simon Hoerstrup (Switzerland)

Human prenatal stem cells for cardiovascular tissue engineering

10.30-11.00 

Peter Ponsaerts (Belgium)

Physiological comparison of autologous and allogeneic cell implantation in the central nervous system: defining and regulating immune cell activity against mesenchymal and neural stem cell grafts

11:00-11:30

Coffee break

11:30-12:00

Francesco Alviano (Italy)
Amniotic membrane-derived stem cells and pancreatic islet-cell differentiation

12:00-12:30

Cesar Borlongan (USA)

Amnion derived cells for cell therapy in stroke

12:30 – 14.00

Lunch with panini and pizza.

14:00

Round Table:

Discussion on applications of placenta-derived cells with young researchers as panellists. Looking toward the next meeting, message on behalf of the IPLASS board.

16:00

Closing address and farewell drinks, with prizes for best oral presentation and poster to be presented by representatives of the awarding Company or Institution.